Cargando…
Differential associations of APOE-ε2 and APOE-ε4 alleles with PET-measured amyloid-β and tau deposition in older individuals without dementia
PURPOSE: To examine associations between the APOE-ε2 and APOE-ε4 alleles and core Alzheimer’s disease (AD) pathological hallmarks as measured by amyloid-β (Aβ) and tau PET in older individuals without dementia. METHODS: We analyzed data from 462 ADNI participants without dementia who underwent Aβ ([...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8175302/ https://www.ncbi.nlm.nih.gov/pubmed/33521872 http://dx.doi.org/10.1007/s00259-021-05192-8 |
_version_ | 1783703025931517952 |
---|---|
author | Salvadó, Gemma Grothe, Michel J. Groot, Colin Moscoso, Alexis Schöll, Michael Gispert, Juan Domingo Ossenkoppele, Rik |
author_facet | Salvadó, Gemma Grothe, Michel J. Groot, Colin Moscoso, Alexis Schöll, Michael Gispert, Juan Domingo Ossenkoppele, Rik |
author_sort | Salvadó, Gemma |
collection | PubMed |
description | PURPOSE: To examine associations between the APOE-ε2 and APOE-ε4 alleles and core Alzheimer’s disease (AD) pathological hallmarks as measured by amyloid-β (Aβ) and tau PET in older individuals without dementia. METHODS: We analyzed data from 462 ADNI participants without dementia who underwent Aβ ([(18)F]florbetapir or [(18)F]florbetaben) and tau ([(18)F]flortaucipir) PET, structural MRI, and cognitive testing. Employing APOE-ε3 homozygotes as the reference group, associations between APOE-ε2 and APOE-ε4 carriership with global Aβ PET and regional tau PET measures (entorhinal cortex (ERC), inferior temporal cortex, and Braak-V/VI neocortical composite regions) were investigated using linear regression models. In a subset of 156 participants, we also investigated associations between APOE genotype and regional tau accumulation over time using linear mixed models. Finally, we assessed whether Aβ mediated the cross-sectional and longitudinal associations between APOE genotype and tau. RESULTS: Compared to APOE-ε3 homozygotes, APOE-ε2 carriers had lower global Aβ burden (β(std) [95% confidence interval (CI)]: − 0.31 [− 0.45, − 0.16], p = 0.034) but did not differ on regional tau burden or tau accumulation over time. APOE-ε4 participants showed higher Aβ (β(std) [95%CI]: 0.64 [0.42, 0.82], p < 0.001) and tau burden (β(std) range: 0.27-0.51, all p < 0.006). In mediation analyses, APOE-ε4 only retained an Aβ-independent effect on tau in the ERC. APOE-ε4 showed a trend towards increased tau accumulation over time in Braak-V/VI compared to APOE-ε3 homozygotes (β(std) [95%CI]: 0.10 [− 0.02, 0.18], p = 0.11), and this association was fully mediated by baseline Aβ. CONCLUSION: Our data suggest that the established protective effect of the APOE-ε2 allele against developing clinical AD is primarily linked to resistance against Aβ deposition rather than tau pathology. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00259-021-05192-8. |
format | Online Article Text |
id | pubmed-8175302 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-81753022021-06-17 Differential associations of APOE-ε2 and APOE-ε4 alleles with PET-measured amyloid-β and tau deposition in older individuals without dementia Salvadó, Gemma Grothe, Michel J. Groot, Colin Moscoso, Alexis Schöll, Michael Gispert, Juan Domingo Ossenkoppele, Rik Eur J Nucl Med Mol Imaging Original Article PURPOSE: To examine associations between the APOE-ε2 and APOE-ε4 alleles and core Alzheimer’s disease (AD) pathological hallmarks as measured by amyloid-β (Aβ) and tau PET in older individuals without dementia. METHODS: We analyzed data from 462 ADNI participants without dementia who underwent Aβ ([(18)F]florbetapir or [(18)F]florbetaben) and tau ([(18)F]flortaucipir) PET, structural MRI, and cognitive testing. Employing APOE-ε3 homozygotes as the reference group, associations between APOE-ε2 and APOE-ε4 carriership with global Aβ PET and regional tau PET measures (entorhinal cortex (ERC), inferior temporal cortex, and Braak-V/VI neocortical composite regions) were investigated using linear regression models. In a subset of 156 participants, we also investigated associations between APOE genotype and regional tau accumulation over time using linear mixed models. Finally, we assessed whether Aβ mediated the cross-sectional and longitudinal associations between APOE genotype and tau. RESULTS: Compared to APOE-ε3 homozygotes, APOE-ε2 carriers had lower global Aβ burden (β(std) [95% confidence interval (CI)]: − 0.31 [− 0.45, − 0.16], p = 0.034) but did not differ on regional tau burden or tau accumulation over time. APOE-ε4 participants showed higher Aβ (β(std) [95%CI]: 0.64 [0.42, 0.82], p < 0.001) and tau burden (β(std) range: 0.27-0.51, all p < 0.006). In mediation analyses, APOE-ε4 only retained an Aβ-independent effect on tau in the ERC. APOE-ε4 showed a trend towards increased tau accumulation over time in Braak-V/VI compared to APOE-ε3 homozygotes (β(std) [95%CI]: 0.10 [− 0.02, 0.18], p = 0.11), and this association was fully mediated by baseline Aβ. CONCLUSION: Our data suggest that the established protective effect of the APOE-ε2 allele against developing clinical AD is primarily linked to resistance against Aβ deposition rather than tau pathology. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00259-021-05192-8. Springer Berlin Heidelberg 2021-02-01 2021 /pmc/articles/PMC8175302/ /pubmed/33521872 http://dx.doi.org/10.1007/s00259-021-05192-8 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Article Salvadó, Gemma Grothe, Michel J. Groot, Colin Moscoso, Alexis Schöll, Michael Gispert, Juan Domingo Ossenkoppele, Rik Differential associations of APOE-ε2 and APOE-ε4 alleles with PET-measured amyloid-β and tau deposition in older individuals without dementia |
title | Differential associations of APOE-ε2 and APOE-ε4 alleles with PET-measured amyloid-β and tau deposition in older individuals without dementia |
title_full | Differential associations of APOE-ε2 and APOE-ε4 alleles with PET-measured amyloid-β and tau deposition in older individuals without dementia |
title_fullStr | Differential associations of APOE-ε2 and APOE-ε4 alleles with PET-measured amyloid-β and tau deposition in older individuals without dementia |
title_full_unstemmed | Differential associations of APOE-ε2 and APOE-ε4 alleles with PET-measured amyloid-β and tau deposition in older individuals without dementia |
title_short | Differential associations of APOE-ε2 and APOE-ε4 alleles with PET-measured amyloid-β and tau deposition in older individuals without dementia |
title_sort | differential associations of apoe-ε2 and apoe-ε4 alleles with pet-measured amyloid-β and tau deposition in older individuals without dementia |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8175302/ https://www.ncbi.nlm.nih.gov/pubmed/33521872 http://dx.doi.org/10.1007/s00259-021-05192-8 |
work_keys_str_mv | AT salvadogemma differentialassociationsofapoee2andapoee4alleleswithpetmeasuredamyloidbandtaudepositioninolderindividualswithoutdementia AT grothemichelj differentialassociationsofapoee2andapoee4alleleswithpetmeasuredamyloidbandtaudepositioninolderindividualswithoutdementia AT grootcolin differentialassociationsofapoee2andapoee4alleleswithpetmeasuredamyloidbandtaudepositioninolderindividualswithoutdementia AT moscosoalexis differentialassociationsofapoee2andapoee4alleleswithpetmeasuredamyloidbandtaudepositioninolderindividualswithoutdementia AT schollmichael differentialassociationsofapoee2andapoee4alleleswithpetmeasuredamyloidbandtaudepositioninolderindividualswithoutdementia AT gispertjuandomingo differentialassociationsofapoee2andapoee4alleleswithpetmeasuredamyloidbandtaudepositioninolderindividualswithoutdementia AT ossenkoppelerik differentialassociationsofapoee2andapoee4alleleswithpetmeasuredamyloidbandtaudepositioninolderindividualswithoutdementia AT differentialassociationsofapoee2andapoee4alleleswithpetmeasuredamyloidbandtaudepositioninolderindividualswithoutdementia |